Heron Therapeutics
HRTX
#8256
Rank
A$0.36 B
Marketcap
A$1.97
Share price
0.00%
Change (1 day)
-22.09%
Change (1 year)

Heron Therapeutics (HRTX) - Net assets

Net assets on the balance sheet as of September 2025 : A$22.4 Million

According to Heron Therapeutics's latest financial reports the company has A$22.4 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Heron Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$54.11 Million8.5%
2023-12-31$-A$49.87 Million-350.02%
2022-12-31$A$19.94 M-81.36%
2021-12-31$A$0.10 B-65.21%
2020-12-31$A$0.30 B-46.68%
2019-12-31$A$0.57 B9.77%
2018-12-31$A$0.52 B212.82%
2017-12-31$A$0.16 B-669.75%
2016-12-31$-A$29.49 Million-118.18%
2015-12-31$A$0.16 B110.41%
2014-12-31$A$77.05 M-0.31%
2013-12-31$A$77.29 M55.01%
2012-12-31$A$49.86 M224.58%
2011-12-31$A$15.36 M1085.79%
2010-12-31$A$1.29 M-82.87%
2009-12-31$A$7.56 M-29.75%
2008-12-31$A$10.76 M-68.06%
2007-12-31$A$33.71 M120.38%
2006-12-31$A$15.29 M80.45%
2005-12-31$A$8.47 M-53.65%
2004-12-31$A$18.29 M20.71%
2003-12-31$A$15.15 M-44.78%
2002-12-31$A$27.43 M-26.96%
2001-12-31$A$37.56 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Alkermes
ALKS
A$2.60 B 11,545.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
A$1.09 B 4,785.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.12 B 471.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.43 B 6,283.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
A$0.16 B 647.79%๐Ÿ‡บ๐Ÿ‡ธ USA